Pharmafile Logo

It’s time to get with the real world

February 11, 2016 |  

Lucid CEO discusses the increasing importance placed on real-world data to demonstrate value

- PMLiVE
In the February issue of PME, Dennis O’Brien (CEO of Lucid) discusses the increasing importance placed on real-world data and how technology has improved measurement. These advances have helped healthcare professionals (HCPs), patients and the industry to better understand diseases, medicines and services. As a result, this has improved the assessment of what factors are actually demonstrating value by improving outcomes for patients.

Dennis goes on to explain how we need to go beyond measuring just the brand and sales picture by anchoring all programmes with metrics that support patient outcomes. For Lucid, this has meant evolving what they measure by focussing more on the specific changes needed in HCP behaviour in order to improve patient outcomes: “if you’re clear about the outcome, you can prioritise the behaviours needed to improve care and then make sure the programme effects these changes.”

Dennis and his team at Lucid have managed to form the strategic client partnerships required to meet the challenge of leveraging real-world data to demonstrate value through behaviour change. To find out how, read the full article here  http://goo.gl/QOq7z2

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

A summer meeting full of magical moments

In their day-to-day, everybody at Lucid Group strives to develop outstanding medical education programmes to improve patient outcomes. Over the summer, however, they like to take some time to turn...

Sir Henry presents Queen’s Award for Enterprise to Lucid Group

On 13 July, Lord Lieutenant Sir Henry presented Lucid Group with the Queen’s Award for Enterprise in International Trade. This award recognises UK-based businesses that have achieved outstanding growth overseas...

Lucid Group’s winning formula is recognised at Communiqué 2017

Lucid Group’s commitment to improving patient outcomes across the globe was recognised at the 2017 Communiqué Awards in London last night. The agency won the awards for Excellence in Communications...

Lucid Partners grows its medical writing team

The past year has been the most successful for Lucid Group yet. They have celebrated their 10th year of business, launched their new Strategic Consultancy, won a Queen’s Award for...

Using insights to effect behaviour change

The days when medical communication simply aimed to raise awareness of clinical challenges are well and truly over. In recent years, we have seen a clear shift towards changing physicians’...

All five of Lucid’s entries reach the shortlist for Communiqué 2017

Lucid Group is thrilled to learn that all its entries for the 2017 Communiqué Awards have been shortlisted as finalists! The categories include: Communications Consultancy of the Year Lucid Group   Excellence in Communications via...

Your career starts here

When working in medical communications, one of the most common questions we get asked is “What is it that you actually do?” Many students and graduates are unaware of medical...

Are you suffering from templatitis?

At times, it feels like procedures are designed to frustrate, and templates often hinder rather than help. Especially in strategic planning, where a certain degree of creativity and innovation is...

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Focus on Rare Diseases

As pharma becomes more focused on rare disease therapies, Lucid Group recognises that medical education agencies need to respond.